Meetings and events

30

May, 2019

Penta ID Network Meeting 2019

Tags:

The Biannual Penta ID Network Meeting (PIM) is once again upon us! Baveno, nestled on the picturesque Lago Maggiore (Italy), welcomes researchers, clinicians and leading international experts in the field of Paediatric Infectious Diseases to discuss relevant scientific topics connected with Penta’s activities worldwide.

READ MORE

28

May, 2019

Islands as Hotspots for Emerging Mosquito-Borne Viruses: A One-Health Perspective

 

Authors: Mavian C, Dulcey M, Munoz O, Salemi M, Vittor AY, Capua I. Published in: Viruses. 2019; 11(1):11 Abstract During the past ten years, an increasing number of arbovirus outbreaks have affected tropical islands worldwide. We examined the available literature in peer-reviewed journals, from the second half of the 20th century until 2018, with the aim of gathering an overall picture of the emergence of arboviruses in these islands. In addition, we included information on environmental and social drivers specific to island setting that can facilitate the emergence of outbreaks. Within […]

READ MORE

28

May, 2019

Article – “R&D for children’s antibiotics: a wake-up call” published in AMR Control

Tags: , , ,

We are delighted to see  an article on children’s antibiotics, co-authored by GARDP R&D Director, Dr Seamus O’Brien, Penta’s Chief Scientific Officer, Prof. Theo Zakoutlis and Prof. Mike Sharland, from St. George’s, University of London, published in AMR Control, as governments have been discussing AMR at the World Health Assembly.

READ MORE

28

May, 2019

R&D for children’s antibiotics – a wake-up call

 

Authors: O’Brien S, Sharland M, Zaoutis T Published in: AMR CONTROL 2019-2020; online edition Abstract It is time to prioritize children’s needs in the context of antimicrobial resistance (AMR). Children, especially babies and young infants, are particularly vulnerable to the rise in drug-resistant infection and need treatments that are adapted to their specific needs. Yet, there are almost no clinical trials looking into children’s antibiotics. This lack of prioritization threatens the attainment of the UN Sustainable Development Goals. The Global Antibiotic Research & Development Partnership (GARDP), Penta, St George’s, University […]

READ MORE

14

May, 2019

Lipidomic analysis reveals serum alteration of plasmalogens in patients infected with ZIKA virus

 

Authors: Queiroz A,Dantas Pinto IF, Lima M, et al. Published in: Front Microbiol. 2019;10:753 Abstract Zika virus (ZIKV) is an arthropod-borne virus (arbovirus) in the Flavivirus genus of the Flaviviridae family. Since the large outbreaks in French Polynesia in 2013-2014 and in Brazil in 2015, ZIKV has been considered a new public health threat. Similar to other related flavivirus, ZIKV is associated with mild and self-limiting symptoms such as rash, pruritus, prostration, headache, arthralgia, myalgia, conjunctivitis, lower back pain and, when present, a short-term low grade fever. In addition, ZIKV has been implicated in neurological […]

READ MORE
NEWSLETTER

We would like to update you on our recent activities